-
Je něco špatně v tomto záznamu ?
Phosphofructokinases A and B from Mycobacterium tuberculosis Display Different Catalytic Properties and Allosteric Regulation
J. Snášel, I. Machová, V. Šolínová, V. Kašička, M. Krečmerová, I. Pichová
Jazyk angličtina Země Švýcarsko
Typ dokumentu srovnávací studie, časopisecké články
Grantová podpora
CZ.02.1.01/0.0/16_019/000729
Ministerstvo Školství, Mládeže a Tělovýchovy
RVO 61388963
Akademie Věd České Republiky
NLK
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
PubMed Central
od 2007
Europe PubMed Central
od 2007
ProQuest Central
od 2000-03-01
Open Access Digital Library
od 2000-01-01
Open Access Digital Library
od 2007-01-01
Health & Medicine (ProQuest)
od 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
PubMed
33540748
DOI
10.3390/ijms22031483
Knihovny.cz E-zdroje
- MeSH
- adenosindifosfát metabolismus farmakologie MeSH
- adenosintrifosfát metabolismus farmakologie MeSH
- alosterická regulace MeSH
- bakteriální proteiny antagonisté a inhibitory metabolismus MeSH
- enzymová indukce MeSH
- fosfofruktokinasy antagonisté a inhibitory metabolismus MeSH
- fruktosadifosfáty biosyntéza farmakologie MeSH
- fruktosafosfáty metabolismus farmakologie MeSH
- glukoneogeneze MeSH
- glykolýza MeSH
- hexosafosfáty metabolismus MeSH
- izoenzymy antagonisté a inhibitory metabolismus MeSH
- katalýza MeSH
- kinetika MeSH
- kyslík farmakologie MeSH
- L-laktátdehydrogenasa metabolismus MeSH
- Mycobacterium tuberculosis účinky léků enzymologie MeSH
- pyruvátkinasa metabolismus MeSH
- rekombinantní proteiny metabolismus MeSH
- substrátová specifita MeSH
- zpětná vazba fyziologická MeSH
- Publikační typ
- časopisecké články MeSH
- srovnávací studie MeSH
Tuberculosis (TB) remains one of the major health concerns worldwide. Mycobacterium tuberculosis (Mtb), the causative agent of TB, can flexibly change its metabolic processes during different life stages. Regulation of key metabolic enzyme activities by intracellular conditions, allosteric inhibition or feedback control can effectively contribute to Mtb survival under different conditions. Phosphofructokinase (Pfk) is one of the key enzymes regulating glycolysis. Mtb encodes two Pfk isoenzymes, Pfk A/Rv3010c and Pfk B/Rv2029c, which are differently expressed upon transition to the hypoxia-induced non-replicating state of the bacteria. While pfkB gene and protein expression are upregulated under hypoxic conditions, Pfk A levels decrease. Here, we present biochemical characterization of both Pfk isoenzymes, revealing that Pfk A and Pfk B display different kinetic properties. Although the glycolytic activity of Pfk A is higher than that of Pfk B, it is markedly inhibited by an excess of both substrates (fructose-6-phosphate and ATP), reaction products (fructose-1,6-bisphosphate and ADP) and common metabolic allosteric regulators. In contrast, synthesis of fructose-1,6-bisphosphatase catalyzed by Pfk B is not regulated by higher levels of substrates, and metabolites. Importantly, we found that only Pfk B can catalyze the reverse gluconeogenic reaction. Pfk B thus can support glycolysis under conditions inhibiting Pfk A function.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019288
- 003
- CZ-PrNML
- 005
- 20210830100852.0
- 007
- ta
- 008
- 210728s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms22031483 $2 doi
- 035 __
- $a (PubMed)33540748
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Snášel, Jan $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 16610 Prague 6, Czech Republic
- 245 10
- $a Phosphofructokinases A and B from Mycobacterium tuberculosis Display Different Catalytic Properties and Allosteric Regulation / $c J. Snášel, I. Machová, V. Šolínová, V. Kašička, M. Krečmerová, I. Pichová
- 520 9_
- $a Tuberculosis (TB) remains one of the major health concerns worldwide. Mycobacterium tuberculosis (Mtb), the causative agent of TB, can flexibly change its metabolic processes during different life stages. Regulation of key metabolic enzyme activities by intracellular conditions, allosteric inhibition or feedback control can effectively contribute to Mtb survival under different conditions. Phosphofructokinase (Pfk) is one of the key enzymes regulating glycolysis. Mtb encodes two Pfk isoenzymes, Pfk A/Rv3010c and Pfk B/Rv2029c, which are differently expressed upon transition to the hypoxia-induced non-replicating state of the bacteria. While pfkB gene and protein expression are upregulated under hypoxic conditions, Pfk A levels decrease. Here, we present biochemical characterization of both Pfk isoenzymes, revealing that Pfk A and Pfk B display different kinetic properties. Although the glycolytic activity of Pfk A is higher than that of Pfk B, it is markedly inhibited by an excess of both substrates (fructose-6-phosphate and ATP), reaction products (fructose-1,6-bisphosphate and ADP) and common metabolic allosteric regulators. In contrast, synthesis of fructose-1,6-bisphosphatase catalyzed by Pfk B is not regulated by higher levels of substrates, and metabolites. Importantly, we found that only Pfk B can catalyze the reverse gluconeogenic reaction. Pfk B thus can support glycolysis under conditions inhibiting Pfk A function.
- 650 _2
- $a adenosindifosfát $x metabolismus $x farmakologie $7 D000244
- 650 _2
- $a adenosintrifosfát $x metabolismus $x farmakologie $7 D000255
- 650 _2
- $a alosterická regulace $7 D000494
- 650 _2
- $a bakteriální proteiny $x antagonisté a inhibitory $x metabolismus $7 D001426
- 650 _2
- $a katalýza $7 D002384
- 650 _2
- $a enzymová indukce $7 D004790
- 650 _2
- $a zpětná vazba fyziologická $7 D025461
- 650 _2
- $a fruktosadifosfáty $x biosyntéza $x farmakologie $7 D005635
- 650 _2
- $a fruktosafosfáty $x metabolismus $x farmakologie $7 D005636
- 650 _2
- $a glukoneogeneze $7 D005943
- 650 _2
- $a glykolýza $7 D006019
- 650 _2
- $a hexosafosfáty $x metabolismus $7 D006600
- 650 _2
- $a izoenzymy $x antagonisté a inhibitory $x metabolismus $7 D007527
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a L-laktátdehydrogenasa $x metabolismus $7 D007770
- 650 _2
- $a Mycobacterium tuberculosis $x účinky léků $x enzymologie $7 D009169
- 650 _2
- $a kyslík $x farmakologie $7 D010100
- 650 _2
- $a fosfofruktokinasy $x antagonisté a inhibitory $x metabolismus $7 D025221
- 650 _2
- $a pyruvátkinasa $x metabolismus $7 D011770
- 650 _2
- $a rekombinantní proteiny $x metabolismus $7 D011994
- 650 _2
- $a substrátová specifita $7 D013379
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Machová, Iva $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 16610 Prague 6, Czech Republic
- 700 1_
- $a Šolínová, Veronika $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 16610 Prague 6, Czech Republic
- 700 1_
- $a Kašička, Václav $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 16610 Prague 6, Czech Republic
- 700 1_
- $a Krečmerová, Marcela $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 16610 Prague 6, Czech Republic
- 700 1_
- $a Pichová, Iva $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 16610 Prague 6, Czech Republic
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 22, č. 3 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33540748 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830100852 $b ABA008
- 999 __
- $a ok $b bmc $g 1690178 $s 1139734
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 22 $c 3 $e 20210202 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- GRA __
- $a CZ.02.1.01/0.0/16_019/000729 $p Ministerstvo Školství, Mládeže a Tělovýchovy
- GRA __
- $a RVO 61388963 $p Akademie Věd České Republiky
- LZP __
- $a Pubmed-20210728